| 1. |
100% income tax exemption for 10 years
commencing from the first year the company derives
profit OR Investment Tax Allowance of 100% on the
qualifying capital expenditure incurred within a
period of 5 years |
| 2. |
Tax exemption on dividends distributed by a BioNexus
company |
| 3. |
Exemption of import duty and sales tax on raw
materials/components and machinery/equipment |
| 4. |
Double deduction on expenditure incurred for R&D |
| 5. |
Double deduction on expenditure incurred for the
promotion of exports |
| 6. |
A company that invests in its subsidiary, which
is a BioNexus Status company, is granted tax deduction
equivalent to the amount of investment made in that
subsidiary provided that the investing company owns
at least 70% of that subsidiary |
| 7. |
A BioNexus company is given concessionary tax
rate of 20% on income from qualifying activities
for 10 years upon the expiry of the tax exemption
period |
| 8. |
A company or an individual investing in a BioNexus
company is given a tax deduction equivalent to total
investment made in seed capital and early stage
financing |
| 9. |
A BioNexus company undertaking merger and acquisition
with a biotechnology company is given exemption
of stamp duty and real property gains tax within
a period of 5 years until 31 December 2011 |
| 10. |
Buildings used solely for the purpose of biotechnology
research activities is given Industrial Building
Allowance over a period of 10 years |
